Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

An AI model has been developed to predict the degree of height growth after treatment with growth hormone drugs. LG Chem said ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Preclinical Psoriasis Data Presented at SID Annual Meeting On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation ...

according to a poster presentation at the Association for Research in Vision and Ophthalmology meeting. Andy Ng and colleagues created an AI model that combined image and parameter data to ...

("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in ...

Session A-2 Room 339: Leverage AI in Psychology: Finding a Use Case Presentation 1: Finding a Use Case: Building a Scheduling GPT: Olivia Velez, Psychology Presentation 2: Finding a Use Case: Natural ...

These posters highlight key data supporting the rationale ... and induced substantial tumor growth inhibition in an in vivo model of YES1-amplified NSCLC. Together, these are the data that ...

In the 'immune warm' CT26 mouse tumor model, vaccine abrogates or slows tumor growth – durable protection against rechallenge supports efficient induction of immune memory; vaccine + αPD1 ...

All poster presentations will take place in Poster Hall I2 ... of mHTT protein in HD patient-derived fibroblasts and clinically relevant BACHD murine model following intrastriatal injections with LETI ...